| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.75 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |